# Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents

> **NCT04336605** · — · UNKNOWN · sponsor: **Norwegian Center for Violence and Traumatic Stress Studies** · enrollment: 25000 (actual)

## Conditions studied

- PTSD
- Psychiatric Illness
- Prescription Drug Dependence
- Addiction

## Interventions

- **OTHER:** Age & Development
- **OTHER:** Socioeconomy
- **OTHER:** Traumatic Events
- **OTHER:** Psychosocial conditions
- **OTHER:** Lifestyle
- **OTHER:** Chronic conditions
- **OTHER:** Somatic symptoms
- **OTHER:** Psychological symptoms
- **OTHER:** Non-prescription analgesics
- **OTHER:** Prescription drugs

## Key facts

- **NCT ID:** NCT04336605
- **Lead sponsor:** Norwegian Center for Violence and Traumatic Stress Studies
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 25000 (ACTUAL)
- **Last updated:** 2020-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04336605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04336605, "Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04336605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*